Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial

This publication has 13 references indexed in Scilit:

• Guidelines on the use of colony‐stimulating factors in haematological malignancies
  British Journal of Haematology, 2003
• Epidemiology and Risk Factors for Gram‐Positive Coccal Infections in Neutropenia: Toward a More Targeted Antibiotic Strategy
  Clinical Infectious Diseases, 2003
• The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period
  Bone Marrow Transplantation, 2002
• Infections during mobilizing chemotherapy and following autologous stem cell transplantation
  Bone Marrow Transplantation, 2001
• 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
  Journal of Clinical Oncology, 2000
• A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults
  Bone Marrow Transplantation, 1999
• Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers
  Bone Marrow Transplantation, 1997
• Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit.
  Journal of Clinical Oncology, 1994
• Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
  The Lancet, 1994
• From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus Panel
  The Journal of Infectious Diseases, 1990